ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P ASX 200
8,235.00
-0.32%
S&P ASX All Technology
3,849.60
-0.26%
Brent Oil
73.705
0.11%
US Dollar vs AUD
1.60305
-0.22%
Bitcoin
93,476.00
-0.05%
Pepperstone
Advertisement
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. Italy
  5. BIT

  6. Philogen Spa (PHIL) Share Price

Philogen Spa

Philogen Spa (PHIL)

Pacific Horizon Investment Trust PLC
Pacific Horizon Investment Trust PLC
Pacific Horizon Investment Trust PLC
PHI Group Inc (PK)
19.20
0.00
( 0.00% )
Updated: 21:32:32
Delayed by 15 minutes

Professional-Grade Tools, for Individual Investors.

Premium

Key stats and details

Current Price
19.20
Bid
19.25
Offer
19.30
Volume
2,138
19.00 Day's Range 19.20
16.30 52 Week Range 21.90
Market Cap
775.634M
Previous Close
19.20
Open
19.00
Last Trade
13
@
19.2
Last Trade Time
21:31:54
Financial Volume
-
VWAP
-
Average Volume (3m)
4,963
Shares Outstanding
40,397,605
Dividend Yield
-
PE Ratio
0.00
Earnings Per Share (EPS)
-
Revenue
25.12M
Net Profit
-6.16M

About Philogen Spa

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
www.philogen.com
Headquarters
Siena, Siena, Ita
Founded
-
Philogen Spa is listed in the Pharmaceutical Preparations sector of the Italian Stock Exchange with ticker PHIL. The last closing price for Philogen was 19.20 €. Over the last year, Philogen shares have traded in a share price range of 16.30 € to 21.90 €.

Philogen currently has 40,397,605 shares in issue. The market capitalisation of Philogen is 775.63 € million.

Ask ADVFN Intelligence (AI)

PHIL Latest News

More News

Philogen provides update on pre-planned interim analysis of the Phase III FIBROSARC trial investigating Onfekafusp alfa (L19TNF) in patients with first-line advanced or metastatic Soft Tissue Sarcoma

Philogen provides update on pre-planned interim analysis of the Phase III FIBROSARC trial investigating Onfekafusp alfa (L19TNF) in patients with first-line advanced or metastatic Soft Tissue...

20 February 2024
GlobeNewswire Inc.

Philogen S.p.A. announces receipt of the Good Manufacturing Practice Certificate for its new Production facility in Rosia (Siena, Italy) by Competent Authorities

Philogen S.p.A. announces receipt of the Good Manufacturing Practice Certificate for its new Production facility in Rosia (Siena, Italy) by Competent Authorities SIENA, Italy, Dec. 05, 2023...

05 December 2023
GlobeNewswire Inc.

Philochem and Blue Earth Diagnostics Announce First Three Patients Imaged in Phase 1 Clinical Trial of 68Ga-OncoFAP (68Ga-OncoFAP-DOTAGA) for Diagnostic Imaging in Solid Tumors

Philochem and Blue Earth Diagnostics Announce First Three Patients Imaged in Phase 1 Clinical Trial of 68Ga-OncoFAP (68Ga-OncoFAP-DOTAGA) for Diagnostic Imaging in Solid Tumors Novel...

04 December 2023
GlobeNewswire Inc.

Nidlegy™ Phase III PIVOTAL trial meets the study’s primary objective demonstrating statistically significant and clinically meaningful improvement in Recurrence-Free Survival for patients with locally advanced fully resectable melanoma

Intratumoral Nidlegy™ followed by surgery significantly improved the Recurrence-Free Survival compared to surgery alone PIVOTAL (NCT02938299) is the first and so far only Phase III trial...

16 October 2023
GlobeNewswire Inc.

Philogen Announces Clinical Trial Collaboration with MSD

Philogen Announces Clinical Trial Collaboration with MSD The Phase II clinical trial investigates Philogen's immunocytokines (i) L19IL2 (ii) L19TNF, and (iii) Nidlegy™ in combination with...

01 June 2023
GlobeNewswire Inc.

Sun Pharma and Philogen enter into an Exclusive Distribution, License, and Supply Agreement for Commercializing specialty product, NIDLEGY™ in Europe, Australia and New Zealand

Sun Pharma and Philogen enter into an Exclusive Distribution, License, and Supply Agreement for Commercializing specialty product, NIDLEGY™ in Europe, Australia and New Zealand Mumbai...

30 May 2023
GlobeNewswire Inc.

Philogen Publishes New Data on a Fibromun-based treatment combination in Science Translational Medicine in collaboration with the University Hospital Zürich

Philogen Publishes New Data on a Fibromun-based treatment combination in Science Translational Medicine in collaboration with the University Hospital Zürich Philogen Publishes New Data on a...

25 May 2023
GlobeNewswire Inc.

Philogen Announces Publication of a New Study in Collaboration with Google focused on Machine Learning models applied to DNA-Encoded Chemical Library Technology

Philogen Announces Publication of a New Study in Collaboration with Google focused on Machine Learning models applied to DNA-Encoded Chemical Library Technology Philogen Announces Publication...

28 March 2023
GlobeNewswire Inc.

Philogen Provides Corporate Update

Philogen Provides Corporate Update Philogen Provides Corporate Update Nidlegy™ and Fibromun pivotal clinical trials on track Fibromun shows potent activity in last-line glioblastoma in...

01 December 2022
GlobeNewswire Inc.
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.31.587301587318.919.318.9348819.1DE
40.050.26109660574419.1519.7518.05544518.80701029DE
12-0.5-2.5380710659919.721.318.05496319.52516438DE
26-0.8-42021.918.05657420.07296869DE
520.552.949061662218.6521.916.3871219.04397182DE
1564.7833.148404993114.4221.913878116.81113105DE
2602.212.94117647061721.912.61212816.01964201DE

PHIL - Frequently Asked Questions (FAQ)

What is the current Philogen share price?
The current share price of Philogen is 19.20 €
How many Philogen shares are in issue?
Philogen has 40,397,605 shares in issue
What is the market cap of Philogen?
The market capitalisation of Philogen is EUR 775.63M
What is the 1 year trading range for Philogen share price?
Philogen has traded in the range of 16.30 € to 21.90 € during the past year
What is the reporting currency for Philogen?
Philogen reports financial results in EUR
What is the latest annual turnover for Philogen?
The latest annual turnover of Philogen is EUR 25.12M
What is the latest annual profit for Philogen?
The latest annual profit of Philogen is EUR -6.16M
What is the registered address of Philogen?
The registered address for Philogen is PIAZZA LA LIZZA, 7, SIENA, SIENA, 53100
What is the Philogen website address?
The website address for Philogen is www.philogen.com
Which industry sector does Philogen operate in?
Philogen operates in the PHARMACEUTICAL PREPARATIONS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
WSGC28SG Company SpA
0.0287 €
(19.58%)
5.5k
MNLMonnalisa SPA
1.75 €
(19.05%)
114.08k
GSPGas Plus Spa
3.02 €
(12.69%)
365.93k
1BYNDBeyond Meat Inc
3.885 €
(11.96%)
1.2k
COSMOFarmacosmo spa
0.932 €
(10.17%)
181.62k
1SRTSartorius AG
183.80 €
(-12.89%)
6
PORPortobello SPA
2.29 €
(-5.76%)
3.6k
FDAFidia
0.0428 €
(-4.89%)
3.43M
1BABoeing Co
164.72 €
(-4.73%)
1.71k
1AWKAmerican Water Works Co Inc
120.60 €
(-4.48%)
1
TITTelecom Italia SpA
0.2465 €
(0.24%)
35.94M
ISPIntesa Sanpaolo Spa
3.881 €
(0.41%)
11.67M
TITRTelecom Italia
0.2903 €
(0.35%)
9.06M
RNRisanamento
0.0294 €
(3.16%)
4.44M
ENELEnel Spa
6.885 €
(0.55%)
4.24M

Discussion

View Full Feed
Penny2Dime Penny2Dime 4 minutes ago
Pre market volume!
MYNA
LowFloatLopes LowFloatLopes 5 minutes ago
I couldn't find any news to justify the drop either especially on such low volume. I got in at roughly $.80 last week. I'll stick with this one for a while and see what happens.
QMMM
Golden Cross Golden Cross 6 minutes ago
$ILLR Triller Is More Than Just An App--A Brief Comprehensive Overview
https://www.youtube.com/watch?v=jHqdI9vhjaw
ILLR
europa7 europa7 6 minutes ago
WISeKey’s Subsidiary SEALCOIN 2025 Roadmap: Leading Machine-to-Machine Transactions Through Blockchain and Space Innovation
December 29, 2024
https://www.globenewswire.com/news-release/2024/12/30/3002441/0/en/WISeKey-s-Subsidiary-SEALCOIN-2025-Roadmap-Leading-Machine-to-Machine-Transac
HBARUSD
Golden Cross Golden Cross 8 minutes ago
$ILLR Triller Is More Than Just An App--A Brief Comprehensive Overview
https://www.youtube.com/watch?v=jHqdI9vhjaw
ILLR
JamesF1 JamesF1 9 minutes ago
I hope prk8r3 answers. I’d like to know if AmeriSource Bergen Stocks Elite Vyvanse yet. Cardinal does not show it yet.
ELTP
JoeMonte1 JoeMonte1 13 minutes ago
We definitely need closure positive or negative.
PSPW
ksquared ksquared 14 minutes ago
CBS News journalist says most underreported 2024 story was Biden’s ‘obvious cognitive decline’
By David Propper Published Dec. 30, 2024, 1:26 a.m. ET
(Too little. Too late. And the gaslighting from the left continues.)

Veteran CBS News reporter Jan Crawford dinged ne
Z06 MAN Z06 MAN 18 minutes ago
Your posts are nothing but opinions… Your conversations with Walter Wee and Ben Hansel mean nothing!!! You care way too much about being right and what others think. No one cares….

Good luck with the New Years resolution…. LMAO
KBLB
ksquared ksquared 20 minutes ago
Donald Trump reacts to Jimmy Carter’s death with heartfelt statement: ‘We all owe him a debt of gratitude’
By Jorge Fitz-Gibbon and David Propper Published Dec. 29, 2024, 5:19 p.m. ET
(Wonder how close to the inauguration the funeral will be held.)

President-elect Don
ksquared ksquared 20 minutes ago
Rest in peace...
Horrible picture.
https://nypost.com/wp-content/uploads/sites/2/2024/12/DECEMBER30.P1_LCF.jpg?resize=400,441&quality=90&strip=all&w=750
georgejjl georgejjl 21 minutes ago
Anavex Life Sciences stock market is set up for a short squeeze that could begin in early 2025 and increase the price by 400% or more.

Good luck and GOD bless,
AVXL
fuagf fuagf 21 minutes ago
Ed Sheeran - Bad Habits [Official Video]

https://www.youtube.com/watch?v=orJSJGHjBLI

Went for hits and got him.
knrorrel knrorrel 25 minutes ago
wow that's/ would bei great
QMMM
ksquared ksquared 28 minutes ago
No argument here... Wouldn't surprise me IF China has them employed ... !!
ksquared ksquared 29 minutes ago
Linda Lavin, Tony-winning Broadway actress who starred in the sitcom ‘Alice,’ dead at 87
By Associated Press Published Dec. 30, 2024, 3:41 a.m. ET

Linda Lavin, a Tony Award-winning stage actress who became a working class icon as a paper-hat wearing waitress on the TV sitcom “
ListenToMe ListenToMe 29 minutes ago
Anyone watching 👀 "ATAI" psycedelic play. 🍄
ATAI
NASDAQ2020 NASDAQ2020 29 minutes ago
I’m beginning to wonder ?
Thx
ELTP
nowwhat2 nowwhat2 31 minutes ago
A huckster is someone who sells something or serves biased interests, using pushy, showy tactics, emojis and song titles.
XRPUSD
NASDAQ2020 NASDAQ2020 32 minutes ago
Free PMs till the 1st.
ELTP
nowwhat2 nowwhat2 34 minutes ago
??????
stocktowatch stocktowatch 34 minutes ago
$CBDW Announces Adnexus Biotechnologies Inc. Groundbreaking AI Technology
https://cbdw.ai/1606-corporation-cbdw-announces-adnexus-biotechnologies-inc-groundbreaking-ai-technology/
CBDW
SkeBallLarry SkeBallLarry 34 minutes ago
Wouldn't surprise me IF China has them employed ... !!
Jackxkr Jackxkr 37 minutes ago
Have to admit LP looks like a genius justwith the new financing compared to Geert at Cel Sci . He really just screwed shareholders it looks like with the new cash raise at.31 .wow.
NWBO
saigai saigai 37 minutes ago
BSLK adding..QSI jumping in
BSLK QSI

Your Recent History

BIT
PHIL
Philogen
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Australia
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads